Several serum biomarkers of inflammatory and proteolytic activity have been investigated in patients with AAA including MMPs, interleukins, CRP and other potential mediators such as TNF-α and TIMP-1 that may contribute to connective tissue degradation and collagen and elastin degeneration. This evidence concerns the gene ELN and triple-A syndrome.